Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 42.69B | 43.38B | 37.62B | 35.47B | 36.27B |
Gross Profit | 10.56B | 11.11B | 9.48B | 8.75B | 8.39B |
EBITDA | 2.81B | 3.28B | 1.92B | 2.06B | -137.90M |
Net Income | 1.68B | 1.84B | 996.36M | 1.23B | -452.45M |
Balance Sheet | |||||
Total Assets | 26.84B | 27.83B | 25.62B | 24.18B | 23.79B |
Cash, Cash Equivalents and Short-Term Investments | 10.46B | 10.05B | 7.29B | 7.53B | 6.42B |
Total Debt | 2.36B | 2.39B | 2.65B | 3.13B | 3.93B |
Total Liabilities | 14.12B | 16.10B | 15.71B | 15.03B | 15.61B |
Stockholders Equity | 12.67B | 11.68B | 9.86B | 9.11B | 8.14B |
Cash Flow | |||||
Free Cash Flow | 1.28B | 3.99B | 394.65M | 2.21B | 792.20M |
Operating Cash Flow | 1.32B | 4.13B | 556.15M | 2.27B | 1.08B |
Investing Cash Flow | -71.25M | -543.46M | 366.40M | -78.33M | -63.87M |
Financing Cash Flow | -830.97M | -826.11M | -1.11B | -1.09B | -108.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥14.66B | 8.27 | 2.79% | -1.59% | -6.38% | ||
63 Neutral | £505.30M | 23.90 | -8.45% | 170.40% | 4.53% | -18.72% | |
― | €910.00M | 8.21 | 10.70% | 6.10% | ― | ― | |
78 Outperform | ¥39.64B | 15.57 | 2.39% | -15.98% | -51.13% | ||
77 Outperform | ¥19.19B | 16.35 | 4.78% | 1.50% | -18.81% | ||
72 Outperform | ¥28.59B | 6.70 | 6.03% | -10.85% | 25.59% | ||
71 Outperform | ¥18.74B | 5.12 | 4.53% | 21.35% | 221.66% |